HomeZVSA • NASDAQ
add
Zyversa Therapeutics Inc
Previous close
$1.11
Day range
$1.04 - $1.14
Year range
$1.04 - $42.34
Market cap
1.12M USD
Avg Volume
2.57M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.27M | -21.81% |
Net income | -2.40M | 17.27% |
Net profit margin | — | — |
Earnings per share | -2.43 | 92.29% |
EBITDA | -2.27M | 21.80% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 122.92K | -92.21% |
Total assets | 19.42M | -40.87% |
Total liabilities | 12.40M | -5.72% |
Total equity | 7.03M | — |
Shares outstanding | 2.34M | — |
Price to book | 0.17 | — |
Return on assets | -29.18% | — |
Return on capital | -72.52% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -2.40M | 17.27% |
Cash from operations | -644.40K | 31.18% |
Cash from investing | — | — |
Cash from financing | 647.84K | -71.67% |
Net change in cash | 3.44K | -99.75% |
Free cash flow | 294.70K | 15.56% |
About
Founded
2014
Headquarters
Website
Employees
7
